Kari Kalliokoski Selected Research

Kari Kalliokoski Research Topics

3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2022 - 01/2015
3	Obesity 01/2022 - 07/2002
3	Hyperinsulinism (Hyperinsulinemia) 01/2003 - 04/2002
2	Insulin Resistance 07/2022 - 12/2021
2	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 10/2021
2	Tendinopathy (Tendonitis) 09/2016 - 07/2014
2	Pain (Aches) 07/2014 - 05/2014
1	Overweight 11/2022
1	Weight Gain 10/2021
1	Feeding and Eating Disorders (Eating Disorder) 01/2021
1	Mental Disorders (Mental Disorder) 01/2020
1	Rupture 09/2016
1	Weight Loss (Weight Reduction) 01/2015
1	Hypertension (High Blood Pressure) 01/2003
1	Essential Hypertension 01/2003
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2002

6	Insulin (Novolin)FDA Link 07/2022 - 04/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2014
3	Adenosine (Adenocard)FDA LinkGeneric 01/2003 - 04/2002
2	RadiopharmaceuticalsIBA 04/2022 - 10/2021
2	EndocannabinoidsIBA 01/2022 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
2	Hormones (Hormone)IBA 10/2021 - 10/2021
1	Oxygen (Dioxygen)IBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Alanine Transaminase (SGPT)IBA 07/2022
1	EnzymesIBA 07/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2022
1	CannabinoidsIBA 01/2022
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022
1	carfentanil (carfentanyl)IBA 01/2020
1	margaric acid (heptadecanoic acid)IBA 01/2015
1	Nonesterified Fatty Acids (NEFA)IBA 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015